Novadoz Pharmaceuticals recalls

FDA enforcement reports naming NOVADOZ PHARMACEUTICALS LLC as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Feb 4, 2026

Severity

Feb 4, 2026Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 ozDrug · NOVADOZ PHARMACEUTICALS LLCFailed Impurities/Degradation SpecificationsClass III